Gav,Ron has backed the wrong horse I think.I reckon the Tully shareholders are looking $40+ dollars a share... the timing of the cap raising just before the release of the Target statement is pretty telling too!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025